News | May 22, 2009

CPC Files Patent for Synthetic Vascular Closure Sealant

May 22, 2009 - CPC of America Inc. filed its first patent of a synthetic sealant for the MedClose Vascular Closure System (VCS), which is an internal puncture-closing system for use in percutaneous intravascular diagnostic and interventional procedures.

The company plans to file patents for more intellectual properties for formulations of synthetic sealants in the MedClose VCS vascular closure product line, which initially will be designed for use with 6-9 Fr. applications.

The MedClose VCS device consists of two parts - a delivery system to release the sealant to the puncture site and the synthetic sealant itself.

The sealing compound is currently undergoing tests in animals. The company said the animal testing to date is not conclusive, but it is pleased with the preliminary results. The company hopes the development of the sealant will resolve outstanding issues with the FDA concerning the company’s application for an investigational device exemption.

For more information: www.cpcmeddevices.com


Related Content

News | Hemostasis Management

October 27, 2021 — Teleflex Inc. announced the completion of patient enrollment in a clinical study evaluating the ...

Home October 27, 2021
Home
News | Hemostasis Management

April 21, 2021 — EnsiteVascular announced it received its second U.S. Food and Drug Administration (FDA) market ...

Home April 21, 2021
Home
Feature | Hemostasis Management | Dave Fornell, Editor

While many cardiac and vascular procedures have largely moved to minimally invasive techniques, the size of these ...

Home March 09, 2021
Home
News | Hemostasis Management

February 8, 2021 — Teleflex Inc. said it recently completed its acquisition of Z-Medica LLC, an industry-leading ...

Home February 08, 2021
Home
News | Hemostasis Management

August 29, 2019 – Merit Medical Systems Inc. announced the U.S. commercial launch of the PreludeSync Evo radial ...

Home August 29, 2019
Home
Technology | Hemostasis Management

February 1, 2019 — Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now available ...

Home February 01, 2019
Home
Videos | Hemostasis Management

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...

Home September 27, 2018
Home
News | Hemostasis Management

August 24, 2016 — Whether severe trauma occurs on the battlefield or the highway, saving lives often comes down to ...

Home August 24, 2016
Home
News | Hemostasis Management

January 6, 2016 — The Medicines Company announced Dec. 18 it has entered into a purchase agreement pursuant to which ...

Home January 06, 2016
Home
Subscribe Now